Portal de recerca
- Inici
- Projectes i Estudis Clínics
- ESTUDIO FASE III, ALEATORIZADO, DOBLE CIEGO, PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE GSK1349572 MAS ABACAVIR/LAMIVUDINA EN COMBINACION A DOSIS FIJAS, ADMINISTRADO UNA VEZ AL DIA FRENTE A ATRIPLA© DURANTE UN PERIODO DE 96 SEMANAS EN PACIENTES ADULTOS IN FECTADOS POR EL VIH-1 QUE NO HAN RECIBIDO TRATAMIENTO ANTIRRETROVIRAL PREVIO.
ESTUDIO FASE III, ALEATORIZADO, DOBLE CIEGO, PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE GSK1349572 MAS ABACAVIR/LAMIVUDINA EN COMBINACION A DOSIS FIJAS, ADMINISTRADO UNA VEZ AL DIA FRENTE A ATRIPLA© DURANTE UN PERIODO DE 96 SEMANAS EN PACIENTES ADULTOS IN FECTADOS POR EL VIH-1 QUE NO HAN RECIBIDO TRATAMIENTO ANTIRRETROVIRAL PREVIO.
Dades bàsiques
- Protocol:
- ING114467
- EURDRACT:
- 2010-020983-39
- NCT:
- Centre:
- Any inici:
- Any de finalització:
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Santos JR; (...); Paredes R
Article. 10.1093/ofid/ofad542. 2023
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimc.2021.05.009. 2021
A survey to describe common practices on antifungal monitoring among Spanish clinicians.
Gomez-Lopez, Alicia, Martin-Gomez, Maria Teresa, Salavert Lleti, Miguel
Article. 10.1016/j.eimce.2021.05.020. 2023
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
de la Asunción CS; (...); Navarro D
Article. 10.1002/jmv.28933. 2023
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH; (...); Vallecillos CG
Article. 10.1016/j.ijantimicag.2024.107164. 2024
Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023
Rodriguez-Leal, Cristobal M.; (...); Salavert, Miguel
Review. 10.37201/req/018.2024. 2024
Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.
Hidalgo-Tenorio, Carmen; (...); Sadyrbaeva-Dolgova, Svetlana
Article. 10.3390/antibiotics12071218. 2023
Climate change, animals, and Candida auris: insights into the ecological niche of a new species from a one health approach.
Garcia-Bustos, Victor; (...); Peman, Javier
Article. 10.1016/j.cmi.2023.03.016. 2023
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
Ferrer, Ricard; (...); McCann, Eilish
Article. 10.37201/req/096.2021. 2021
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007. 2023
CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.
Article. 10.1016/j.jtct.2024.01.082. 2024
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Babich, T; (...); Yahav, D
Article. 10.1093/jac/dkab134. 2021
Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
De La Puerta R; (...); Piñana JL
Article. 10.1038/s41409-021-01319-5. 2021
Corrigendum to "Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients" [International Journal of Infectious Diseases 144 (2024) 107070].
Monzó-Gallo P; (...); Garcia-Vidal C
Correction. 10.1016/j.ijid.2024.107188. 2024
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Current approach to skin and soft tissue infections. Thinking about continuity of care.
Blanes Hernández R; (...); Salavert Lletí M
Article. 10.37201/req/s01.10.2023. 2023
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Vidal-Cortes, Pablo; (...); Zaragoza, Rafael
Review. 10.3390/antibiotics11091160. 2022
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.
Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina
Article. 10.1093/mmy/myac038. 2022
Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; (...); Pemán J
Article. 10.1128/Spectrum.00013-21. 2021
Dalbavancin in clinical practice in Spain: a 2 year retrospective study.
Morata, Laura; (...); Almirante, Benito
Article. 10.1093/jacamr/dlac120. 2022
Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study.
Morata Ruiz L; (...); Grossi PA
Article. 10.1016/j.jgar.2023.11.015. 2024
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
Podzamczer D; (...); Moreno S
Article. 10.1093/ofid/ofab595. 2022
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
Canton, Rafael; (...); Gonzalez del Castillo, Juan
Article. 10.37201/req/172.2021. 2022
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimce.2021.07.003. 2021
Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis.
Asensi Cantó P; (...); Guerreiro M
Article. 10.1111/tid.14067. 2023
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
Garcia-Bustos, V; (...); Munoz, EC
Editorial Material. 10.3389/fcimb.2021.671962. 2021
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral
Article. 10.3390/v14030524. 2022
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya, Jesus; (...); Buzon, Luis
Article. 10.1097/MD.0000000000029252. 2022
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Babich T; (...); Yahav D
Article. 10.1007/s40121-022-00657-1. 2022
Dysimmunity in common variable immunodeficiency is associated with alterations in oral, respiratory, and intestinal microbiota.
Cabanero-Navalon, Marta Dafne; (...); Carda-Dieguez, Miguel
Article. 10.1016/j.clim.2023.109796. 2023
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Gutierrez, Felix; (...); Masia, Mar
Article. 10.1093/cid/ciae359. 2024
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Moreno-Garcia, E; (...); Garcia-Vidal, C
Article. 10.1093/ofid/ofab250. 2021
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
Corona, Diana; (...); Rivero, Antonio
Article. 10.1016/j.ijantimicag.2023.107016. 2024
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
Santos JR; (...); Paredes R
Article. 10.3389/fcimb.2023.1187999. 2023
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
Suarez-Garcia, I.; (...); Jarrin, I.
Meeting Abstract. 2021
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
Palacios, R.; (...); Santos, J.
Article. 10.1111/hiv.13489. 2023
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R; (...); Espinosa, N
Article. 10.1080/25787489.2021.1955197. 2021
Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.
Blanes Hernández R, Blanes Juliá M
Article. 10.37201/req/s01.01.2023. 2023
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C; (...); González Garcia J
Article. 10.1111/hiv.13229. 2022
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.
Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor
Article. 10.37201/req/s01.20.2022. 2022
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
Ruiz-Rodriguez P; (...); Coscolla M
Article. 10.1128/mBio.02315-21. 2021
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2.
Candel, Francisco Javier; (...); On Behalf Of The Modus Investigators Adenda
Article. 10.3390/v15071449. 2023
Factors associated with late presentation for HIV care in adolescents in Spain
Epalza, Cristina; (...); Luisa Navarro, Maria
Article. 10.1111/hiv.13407. 2022
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Escudero-Sanchez, Rosa; (...); Cobo Reinoso, Javier
Article. 10.1093/jac/dkac106. 2022
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
Perez-Latorre, L; (...); Gonzalez-Garcia, J
Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021
Host-pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella
Garcia-Bustos, Victor; (...); Ruiz-Sauri, Amparo
Article. 10.1080/22221751.2021.2017756. 2022
How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations
Fernandez-Ruiz, Mario; (...); Aguado, Jose Maria
Article. 10.1016/j.eimc.2024.06.003. 2024
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernandez-Ruiz, Mario; (...); Abril, Vicente
Article. 10.1016/j.eimce.2024.07.001. 2024
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; (...); Martínez E
Article. 10.1186/s13063-021-05777-6. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)
Masia, M.; (...); Martinez, E.
Correction. 10.1186/s13063-023-07655-9. 2023
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini, Cristina; (...); van Wyk, Jean
Article. 10.1007/s10461-024-04490-0. 2024
Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.
Chorao, Pedro; (...); Sanz, Jaime
Article. 10.1016/j.jtct.2024.12.006. 2024
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H; (...); Poveda E
Article. 10.3389/fimmu.2023.1257725. 2023
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007_g. 2023
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez
Article. 10.1016/j.eimc.2023.07.005. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.
Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo
Article. 10.1016/j.eimce.2023.07.009. 2023
Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report
Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero
Editorial Material. 10.1016/j.eimc.2024.02.008. 2024
Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.
Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta
Case Reports. 10.1016/j.eimce.2024.04.004. 2024
Lack of evidence for infectious SARS-CoV-2 in feces and sewage
Albert, Sandra; (...); Domingo-Calap, Pilar
Article. 10.1007/s10096-021-04304-4. 2021
Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.
Cabanero-Navalon MD; (...); Garcia-Bustos V
Article. 10.3390/biomedicines12102239. 2024
Long or complicated mpox in patients with uncontrolled HIV infection.
Corma-Gómez A; (...); Macías J
Article. 10.1002/jmv.29511. 2024
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ
Article. 10.1016/j.biopha.2023.114587. 2023
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Correction. 10.1016/j.kint.2024.10.002. 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Article. 10.1016/j.kint.2024.04.010. 2024
Management of congenital and acquired airway pathologies in newborns by a cross-disciplinary committee at a third level hospital.
Costa-Roig A; (...); Vila JJ
Article. 2021
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
Bernardino, Jose I.; (...); Rodes, Berta
Article. 10.3390/microorganisms11071818. 2023
Mucormycosis: Current and future management perspective
Gomez, MTM, Lleti, MS
Article. 10.1016/j.riam.2021.04.003. 2021
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.
Moral Moral, Pedro; (...); Salavert Lleti, Miguel
Article. 10.37201/req/s03.14.2022. 2022
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
Papel de cefditoreno en el tratamiento de las infecciones comunitarias de piel y tejidos blandos: revisando la evidencia.
Cabañero-Navalón MD, García-Bustos V, Salavert Lletí M
Review. 10.37201/req/063.2021. 2021
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Llibre, Josep M; (...); Alcantara, Felipe Rodriguez
Article. 10.1111/hiv.13650. 2024
Prospective cohort study on hospitalised patients with suspected urinary tract infection and risk factors por multidrug resistance.
Garcia-Bustos V; (...); Lletí MS
Article. 10.1038/s41598-021-90949-2. 2021
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Valencia ME; (...); González J
Article. 10.1016/j.eimce.2024.05.005. 2024
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
Teira, Ramon; (...); Berenguer, Juan
Article. 10.1371/journal.pone.0249515. 2021
Recommendations for antibiotic selection for severe nosocomial infections
Mensa, Josep; (...); Soriano, Alex
Article. 10.37201/req/126.2021. 2021
Recommendations on the use of azole antifungals in hematology-oncology patients
Azanza, Jose Ramon; (...); Gutierrez, Carlos Duenas
Review. 10.37201/req/013.2023. 2023
Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies
Javier Candel, Francisco; (...); Cuervo Pinto, Rafael
Review. 10.37201/req/023.2023. 2023
Response to Vaccines in Patients with Immune-Mediated Inflammatory Diseases: A Narrative Review.
Garcillan, Beatriz; (...); Diaz-Castroverde, Sabela
Article. 10.3390/vaccines10020297. 2022
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
Salto-Alejandre, S; (...); Cordero, E
Article. 10.1371/journal.pone.0250796. 2021
Safety and effectiveness of isavuconazole in real-life non-neutropenic patients.
Monzo-Gallo, Patricia; (...); Garcia-Vidal, Carolina
Article. 10.1016/j.ijid.2024.107070. 2024
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Teira, Ramon; (...); Curran, Adria
Article. 10.1007/s40121-022-00630-y. 2022
Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis
Podzamczer, D.; (...); Rivero, A.
Meeting Abstract. 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer, Daniel; (...); Rivero, Antonio
Article. 10.1093/jac/dkad285. 2023
Tedizolid: new data and experiences for clinical practice.
Salavert Lleti, M; (...); Cabanero-Navalon, M D
Article. 10.37201/req/s01.06.2021. 2021
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Serrano, Leyre
Article. 10.3390/jcm12216864. 2023
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.3390/jcm12206526. 2023
The Challenge of Treating Infections Caused by Metallo-ß-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.
Hidalgo-Tenorio C; (...); Martínez-Martínez L
Article. 10.1007/s40265-024-02102-8. 2024
The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
Membrillo de Novales FJ; (...); Hidalgo-Tenorio C
Article. 10.1093/cid/ciae123. 2024
The role of rapid multiplex molecular syndromic panels in the clinical management of infections in critically ill patients: an experts-opinion document.
Candel, Francisco Javier; (...); Zaragoza, Rafael
Article. 10.1186/s13054-024-05224-3. 2024
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses.
Alonso-Navarro, Rodrigo; (...); Soriano, Alex
Article. 10.1186/s12879-023-08222-y. 2023
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Vinuela, Laura; (...); Garcia, Federico
Article. 10.1002/jmv.29287. 2023
Tratamiento y prevención de la viruela del mono.
de la Calle-Prieto F; (...); Membrillo FJ
Article. 10.1016/j.eimc.2022.08.001. 2022
Treatment and prevention of monkeypox
Calle-Prieto, Fernando de la; (...); , TERDDPUGDDIYGDDDDS
Review. 10.1016/j.eimc.2022.08.0010213-005X. 2023
Treatment and prevention of monkeypox.
de la Calle-Prieto, Fernando; (...); Membrillo, Francisco Javier
Article. 10.1016/j.eimce.2022.12.010. 2023
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Alguero, Marta; (...); Jarrin, Inma
Article. 10.1111/hiv.13469. 2023
What Do We Know about Candida auris ? State of the Art, Knowledge Gaps, and Future Directions.
Garcia-Bustos V; (...); Pemán J
Article. 10.3390/microorganisms9102177. 2021